Skip to main content
. 2017 Aug 6;8(40):66925–66939. doi: 10.18632/oncotarget.19963

Figure 5. Mitochondrial complex I and II proteins are associated with poor clinical outcome in ovarian cancer patients.

Figure 5

A. Note that high levels of NDUFA3 and NDUFB11 predict significantly reduced overall survival. B. Similarly, high levels of SDHC predict significantly reduced overall survival.